ECOG is as independent predictor of the response to chemotherapy, overall survival and progression-free survival in carcinoma of unknown primary site.

导出 LinkOut

翻译打印收藏纠错

作者： Rocío,Grajales-Álvarez ^[1] ; Ana,Martin-Aguilar ^[1] ; Juan A,Silva ^[1] ; Jaime G,De La Garza-Salazar ^[2] ; Erika,Ruiz-García ^[3] ; César,López-Camarillo ^[4] ; Laurence A,Marchat ^[5] ; Horacio Astudillo-De,La Vega ^[6]

作者单位： Oncology Hospital, National Medical Center, 'Century XXI', IMSS, México City 06720, México. ^[1] Clinic of Thoracic Oncology, National Institute of Cancerology, México City 14080, México. ^[2] Translational Medicine Laboratory, National Institute of Cancerology, México City 14080, México. ^[3] Oncogenomics Laboratory, Autonomous University of México City, México City 03100, México. ^[4] Molecular Biomedicine Program and Biotechnology Program, National School of Medicine and Homeopathy, Instituto Politecnico Nacional, México City 07320, México. ^[5] Translational Research Laboratory, Oncology Hospital, National Medical Center, 'Century XXI', IMSS, México City 06720, México. ^[6]

关键词 Eastern Cooperative Oncology Group carcinoma of unknown primary site chemotherapy overall survival progression-free survival

DOI 10.3892/mco.2017.1209

PMID 28515916

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览25

Molecular and clinical oncology

2017年6卷5期

643-650页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

ECOG is as independent predictor of the response to chemotherapy, overall survival and progression-free survival in carcinoma of unknown primary site.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

ECOG is as independent predictor of the response to chemotherapy, overall survival and progression-free survival in carcinoma of unknown primary site.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

检索历史清除